Effect of Polyphenol-rich Dark Chocolate on Body Weight in Overweight and Obese Adults
NCT ID: NCT01749852
Last Updated: 2014-10-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
14 participants
INTERVENTIONAL
2013-01-31
2014-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Polyphenol-rich Dark Chocolate on Insulin Sensitivity in Normal Weight and Overweight Adults
NCT01749020
Effect of Polyphenol-rich Dark Chocolate on Obesity
NCT00815451
Effects of Flavanol-rich Dark Chocolate Consumption on Metabolic Profiles Among Obese Adults Using Metabolomics Approach
NCT04347304
Efficacy of Polyphenols From Milk and Dark Chocolate
NCT00513344
Polyphenol Bioavailability From Chocolate
NCT00492713
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Polyphenol-rich Dark chocolate
Dark chocolate with 500 mg of polyphenols
Polyphenol-rich Dark chocolate
Participants will be asked to consume 20g of dark chocolate containing 500mg of polyphenols daily for a period of 12 weeks
Placebo Dark chocolate
This chocolate contains little or no polyphenols
Placebo Dark chocolate
Participants will be asked to consume 20g of dark chocolate containing little or no polyphenols for a period of 12 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Polyphenol-rich Dark chocolate
Participants will be asked to consume 20g of dark chocolate containing 500mg of polyphenols daily for a period of 12 weeks
Placebo Dark chocolate
Participants will be asked to consume 20g of dark chocolate containing little or no polyphenols for a period of 12 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI between 25-35
* Males and Females
* Age: 18-65 years
Exclusion Criteria
* Participants taking any medications that affect insulin, cholesterol, triglycerides or Blood pressure
* Participants who recently participated or are currently on a weight management program
* Participants with regular consumption of cocoa or DC (\> 1 serving/week)
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Barry Callebaut
UNKNOWN
Queen Margaret University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Grace Farhat
PhD research student
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emad Al-Dujaili, PhD
Role: STUDY_DIRECTOR
Queen Margaret University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Queen Margaret University Lab
Musselburgh, East Lothian, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DC-BW 01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.